University of Vermont Medical Center
Background data
Program Type : Adult ProgramFACT Approved: Yes
Year CAR T-cell Therapy Program Opened:
Location Info
University of Vermont Medical CenterVermont Cancer Center
111 Colchester Ave
Burlington, , 05401
Burlington, , 05401
Website : https://www.uvmhealth.org/medcenter/departments-and-programs/hematology-and-oncology
CAR T-cell therapies performed
Numbers displayed are the most recent data provided by this center.| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Number performed | - | - | 9 | 9 | 17 |
Program Director
| Name | Phone |
|---|---|
| James Gerson, MD | (802) 656-5465 |
| Julian Sprague, MD, PhD | (802) 656-5415 |
Medical Director
| Name | Phone |
|---|---|
| James Gerson, MD | (802) 656-5465 |
| Julian Sprague, MD, PhD | (802) 656-5415 |
Physician
| Name | Phone |
|---|---|
| Diego Adrianzen, MD | (802) 656-5465 |
| Mansour Gergi, MD | (802) 656-5465 |
| James Gerson, MD | (802) 656-5465 |
| Sakshi Jasra, MD | (802) 656-5462 |
| Julian Sprague, MD, PhD | (802) 656-5415 |
| Ryan Thomas, RN | (802) 656-5465 |
Coordinator
| Name | Phone |
|---|---|
| Katelynn Kaffenberger, BSN, RN, OCN, TCTCN | (802) 847-3206 |
| Matthew Whooley, RN, OCN, TCTCN | (802) 847-5649 |
Diseases treated by CAR T-cell therapy
- Leukemia, acute lymphoblastic
- Mantle Cell Lymphoma
- Multiple Myeloma
CAR T-Cell products
- Abecma (idecabtagene vicleucil, ide-cel)
- Breyanzi (lisocabtagene maraleucel, liso-cel)